Resource Logo
Reuters New Media

Quest, Stanford Find Antiviral Resistant HIV


TETERBORO, N.J. (Reuters) - Quest Diagnostics Inc., a provider of gene-based medical testing, information and services, said on Tuesday that it and the Center for AIDS Research at the Stanford University School of Medicine have found strain of HIV-1 that is resistant to antiviral drugs.

The strain has reduced susceptibility to reverse transcriptase inhibitors, a class of antiviral drugs, Quest said.

Identification of this new mutation gives physicians additional information that allows them to better target effective treatment of HIV-1 in their patients, Quest said.

The findings, which were published in the November Journal of Virology, are being used by Quest to report laboratory results for its HIV-1 genotyping test, the company said.


Copyright © 2000 -Reuters New Media, Publisher. All rights reserved to Reuters .Ltd. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Information in this article was accurate in December 12, 2000. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.